ProPhase Labs/$PRPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About ProPhase Labs
ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.
Ticker
$PRPH
Sector
Trading on
Industry
Pharmaceuticals
Headquarters
Employees
96
ISIN
US74345W1080
Website
ProPhase Labs Metrics
BasicAdvanced
$13M
-
-$1.73
-
-
Price and volume
Market cap
$13M
52-week high
$5.45
52-week low
$0.22
Average daily volume
1.5M
Financial strength
Current ratio
1.03
Quick ratio
0.844
Long term debt to equity
54.253
Total debt to equity
92.651
Interest coverage (TTM)
-10.05%
Management effectiveness
Return on assets (TTM)
-30.92%
Return on equity (TTM)
-162.30%
Valuation
Price to revenue (TTM)
1.311
Price to book
0.84
Price to tangible book (TTM)
16.29
Price to free cash flow (TTM)
-0.485
Growth
Revenue change (TTM)
-79.64%
Earnings per share change (TTM)
27.30%
3-year revenue growth (CAGR)
-62.55%
3-year earnings per share growth (CAGR)
19.18%
What the Analysts think about ProPhase Labs
Analyst ratings (Buy, Hold, Sell) for ProPhase Labs stock.
ProPhase Labs Financial Performance
Revenues and expenses
ProPhase Labs Earnings Performance
Company profitability
ProPhase Labs News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ProPhase Labs stock?
ProPhase Labs (PRPH) has a market cap of $13M as of May 23, 2025.
What is the P/E ratio for ProPhase Labs stock?
The price to earnings (P/E) ratio for ProPhase Labs (PRPH) stock is 0 as of May 23, 2025.
Does ProPhase Labs stock pay dividends?
No, ProPhase Labs (PRPH) stock does not pay dividends to its shareholders as of May 23, 2025.
When is the next ProPhase Labs dividend payment date?
ProPhase Labs (PRPH) stock does not pay dividends to its shareholders.
What is the beta indicator for ProPhase Labs?
ProPhase Labs (PRPH) does not currently have a Beta indicator.